ADAR1 also enhances cancer cell survival, proliferation, and metastasis by editing miRNAs and their target sites, thereby dysregulating key signaling networks like the PI3K-AKT and RAS pathways (Wang Z. et al., 2025; Hata et al., 2023). Here, ADAR is linked to cancer.